Corrigendum: Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy

The authors wish to apologize for errors in the legend of Figure 7. The legend has been corrected to the following: ``Figure 7. Expression of HA-NRG1 type III transgene increases PMP2 protein level (A) Western blot analysis from WT, Nrg1t3, Q215X, Nrg1t3;Q215X, Mek1DD;P0Cre and Mek1DD;P0Cre;Q215X sciatic nerves at one month. Expression of HA-NRG1t3 transgene in sciatic nerves or constitutive activation the MAPK/ERK pathway in Schwann cells leads to an increase in ERK phosphorylation, a decrease in EGR2 protein levels and an increase in PMP2 protein levels. These effects are enhanced in Mek1DD;P0Cre mutants as compared to HA-NRG1t3 mutants. Western blots were cropped. Semithin cross-sections stained with toluidine blue (B) and nerve conduction velocity (C) from wildtype (WT), Nrg1t3 hemizygote (Nrg1t3), P0Q215X heterozygote (Q215X) and Nrg1t3 hemizygote and P0Q215X heterozygote (Nrg1t3;Q215X) sciatic nerves at one year.''